Matasar, M., Jandl, T. A., Assi, R., Kuriakose, P., Iragavarapu, C., Illmer, T., Goldschmidt, N., Avigdor, A., Jeon, Y., Ong, S., Yannakou, C. K., Sia, H., Shin, H. J., Wong, L., Villambrosia, S. G. D., Kori, A. N., Vriendt, C. D., Cao, A., Iqbal, N., Michot, J. (2026). First-line odronextamab (Odro) plus chemotherapy (CHOP) in diffuse large B-cell lymphoma (DLBCL): OLYMPIA-3 Part 1B results.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7009